KELLY HUFFMAN: Open Payments
NPI 1225452535 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 67 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $167 · 2025 $1,563
Food & beverage: $1,563
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $288 |
| Vanda Pharmaceuticals Inc. | 12 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $246 |
| Janssen Pharmaceuticals, Inc | 4 | $197 |
| Teva Pharmaceuticals USA, Inc. | 11 | $152 |
| E.R. Squibb & Sons, L.L.C. | 4 | $143 |
| Alkermes, Inc. | 4 | $90 |
| ABBVIE INC. | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Indivior Inc. | 2 | $44 |
Products named: CAPLYTA, HETLIOZ, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, FANAPT, REXULTI, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
